Introduction {#S0001}
============

Time voltage area of QRS is closely linked to modifications in R-R interval length during stress time and during recovery time in normal subjects, probably as a consequence of endoventricular volume variations \[[@CIT0001]\].

In the present study we want to investigate modifications in time voltage area of QRS during haemodialytic treatment (HT). Haemodialytic treatment represents a clinical experimental model in which progressive reduction in endoventricular volume represents *per se* the most important component affecting QRS voltage, in absence of significant variations in R-R interval length, diversely by the stress test model.

Increased QRS amplitude has been reported in a single lead (V5) or in XYZ Frank leads at the end, with respect to the start of HT \[[@CIT0002], [@CIT0003]\], except for Ojanen *et al*., who monitored QRS vector difference changes during the entire HT \[[@CIT0004]\]. To our knowledge, no study has evaluated the change in time voltage area during the entire HT.

The aim of the study was to investigate the efficacy of time voltage area of QRS in identifying the progressive decrease in blood volume (BV) in a group of patients who underwent to HT.

Material and methods {#S0002}
====================

Thirteen chronic uraemic patients, 7 male, 6 female (mean aged 59 ±19 years) have been monitored during HT in the Haemodialysis Unit of Urology Department, University of Sapienza, Rome. Clinical characteristics of the population are shown in [Table I](#T0001){ref-type="table"}.

###### 

Clinical characteristics of patients undergoing haemodialytic treatment

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------
  Number of patients                                                                                                                                                     13
  Male                                                                                                                                                                   7
  Female                                                                                                                                                                 6
  Mean age \[years\]                                                                                                                                                     56 ±19
  Duration of HT \[years\]                                                                                                                                               1-15
  HT length \[h\]                                                                                                                                                        3-4
  Types of nephropathies, *n*:                                                                                                                                           
   Glomerulonephritis                                                                                                                                                    4
   Polycystic kidney                                                                                                                                                     2
   Berger disease                                                                                                                                                        1
   Goodpasture syndrome                                                                                                                                                  1
   Urethral stenosis                                                                                                                                                     1
   Diabetic nephropathy                                                                                                                                                  1
   Nephroangiosclerosis                                                                                                                                                  1
   Cancer kidney                                                                                                                                                         1
   Systemic lupus erythematosus                                                                                                                                          1
  Associated pathologies, *n*:                                                                                                                                           
   Hypertension                                                                                                                                                          13
   Hypothyroidism                                                                                                                                                        4
   Secondary hyperparathyroidism                                                                                                                                         2
   Paroxysmal atrial fibrillation                                                                                                                                        1
  Drugs: diuretics, anticoagulants, calcium channel blockers, ACE inhibitors, angiotensin receptor blockers, l-thyroxine, vitamin D, calcium carbonate, erythropoietin   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------

Standard 12-lead ECG was continuously monitored before, during and after HT with a Norav Medical Ltd. device. Dedicated software was used to extract X, Y, Z like leads from standard 12-lead ECG. Subsequently time voltage area in each QRS complex in XYZ like leads was computed as the time integral from the onset to the offset of QRS \[[@CIT0001]\]. Summation of areas of each QRS complex in XYZ like leads was named total area (TA). QRS TA values were obtained in each patient, as a mean of every minute beat-to-beat value. BV loss percentage was obtained from the difference of values measured every 15 min. Echocardiography was performed before HT in all patients to exclude pericardial effusion. Bundle branch block, ventricular pre-excitation, pacemakers, atrial fibrillation and acute myocardial ischemia during HT were considered exclusion criteria because they can affect, *per se*, with different mechanisms, QRS area \[[@CIT0005]--[@CIT0007]\]. Age, gender, race, and ventricular mass were not considered as our study concerns intra-individual variability of QRS area. To exclude change in heart\'s position, relative to the chest wall, the patients were maintained in the same decubitus during HT.

The variables reported in [Table II](#T0002){ref-type="table"} were measured before and after the HT. Statistical evaluation was performed to exclude the influence during HT of variables able to modify QRS amplitude such as heart rate, haemoglobin, red cell number, and intra-myocardial conduction delay, in addition to BV loss \[[@CIT0007], [@CIT0008]\].

###### 

Statistical significance of differences in mean values of variables evaluated before and after haemodialytic treatment in 13 chronic uraemic patients

  Variable                      Pre HT   Post HT   Value of *p*
  ----------------------------- -------- --------- --------------
  Total area QRS \[mV × ms\]    333      403       \< 0.01
  Blood volume \[%\]            100      91.1      \< 0.0001
  Weight \[kg\]                 69.5     66.5      \< 0.003
  Blood pressure \[mm Hg\]      140/83   135/79    NS
  Heart rate \[bpm\]            77       77        NS
  Red cells \[million/mm^3^\]   3.2      3.1       NS
  Haemoglobin \[g/dl\]          12.4     13.9      NS
  Haematocrit \[%\]             80       83        NS
  QRS length \[ms\]             40.3     42.3      NS
  PH                            7.33     7.44      \< 0.0001
  Creatinine \[mg/dl\]          10.1     4.1       \< 0.0001
  Azotaemia \[mg/dl\]           73.07    28.77     \< 0.002
  Ca^2+^ \[mg/dl\]              8.16     9.84      \< 0.005
  K^+^ \[mEq/l\]                5.52     3.77      \< 0.0008
  Na^+^ \[mEq/l\]               134.32   141.55    \< 0.0001
  Phosphataemia \[mg/dl\]       6.122    2.65      \< 0.0001

Statistical analysis {#S20003}
--------------------

Mean values of variables listed in [Table II](#T0002){ref-type="table"} at the start and at the end of HT were compared using Student\'s *t*-test. Statistical significance was considered for *p* value \< 0.05. We considered the relationship between the following two variables: the QRS TA and the percentage of BV loss. The statistical analysis was performed with the software R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL <http://www.R-project.org>).

Results {#S0004}
=======

A significant increase in QRS TA and a significant decrease in circulating BV were found after vs. before HT. QRS TA increase is gradual during HT and closely related to the reduction of BV. A BV loss of 1% involves a QRS TA increase of 10 units.

No statistical difference was found between all other variables, i.e. heart rate, QRS length, red cell number and haematocrit value before and after HT ([Table II](#T0002){ref-type="table"}).

Discussion {#S0005}
==========

It is difficult to find a unitary pathogenetic interpretation to explain changes in QRS amplitude during stress test or during HT or in heart failure, blood transfusion, myocarditis, and pericarditis and in myocardial ischaemia. In clinical models, many factors are able to modify QRS amplitude.

Proposed pathogenetic mechanisms are often in contrast with theoretical analysis (Brody effect) \[[@CIT0009]\]. Recently, Madias has proposed a "3-Compartment Mechanistic Model" to explain the attenuation of the electrocardiographic QRS complexes observed in patients with blood volume overload \[[@CIT0010]\]. This pathogenetic hypothesis could be able to explain our results.

The 1^st^ compartment, according to Madias, includes the effects of increased intraventricular blood volume and decreased haematocrit, due to blood dilution, the 2^nd^ compartment includes the heart\'s alteration in electrogenesis, due to possible ischaemia or inflammation, leading to myocardial oedema, and the 3^rd^ compartment includes the passive volume conductor of tissue and organ constituents of the thorax and the entire body (pulmonary and peripheral oedema).

In the absence of a significant increase of haematocrit value at the end of HT vs. before HT, only the reduction in BV would influence the QRS TA increase in our patients. The lack of difference in heart rate after vs. before HT allows us to exclude modifications in left ventricular diastolic filling as a cause of increased QRS TA value.

The influence of the 2^nd^ compartment can be excluded by the absence of ischaemic symptoms with typical ECG abnormalities and by the absence of intraventricular conduction delay during HT.

The influence of the 3^rd^ compartment can be excluded by the absence of pericardial effusion before HT. We cannot exclude "tegument oedema", as a possible variable influencing QRS TA, despite the patients in chronic dialysis having mild generalized oedema. Moreover, a redistribution of generalized oedema in such a short time (mean HT time 4 h) seems unlikely.

In conclusion, changes in QRS TA, observed during the HT treatment, should reflect variations in intraventricular volume, since we excluded many of the possible confounding factors listed in Madias' model. We found a strong inverse correlation between the increase in QRS TA and the reduction of BV (BV loss of 1% leads to a QRS TA increase of 10 units).

The results of this pilot study, despite the small number of patients, encourage to use monitoring of QRS TA during haemodialysis to prevent excessive or insufficient subtractions of water with consequent hypotensive or cardiorespiratory crisis, frequent complications in these patients.
